#None #New York #Freda Biotech #Key C #Collagen Technology

Innovative Advances in Collagen Delivery at SCC79

In an impressive display of scientific progress, Shandong Freda Biotech Co., Ltd. presented groundbreaking research focused on collagen delivery systems, aimed at enhancing skin rejuvenation products at the Society of Cosmetic Chemists' 79th Annual Meeting (SCC79) in New York. The highlight of the presentation was the introduction of new methods for delivering high-molecular-weight recombinant human Type III collagen (RHC-III), which has the potential to revolutionize the anti-aging landscape in the skincare industry.

The presentation was labeled "Transcending Skin Barriers: Innovative Delivery Strategies for High-Molecular-Weight Recombinant Human Collagen III." This topic attracted attention from industry leaders and attendees alike, showcasing Freda’s commitment to pushing the boundaries of collagen application in cosmetics and medical aesthetics. Over the years, the efficacy of topical collagen has been under scrutiny, mainly due to concerns about its ability to penetrate the skin effectively. Traditionally, the use of low-molecular-weight collagen fragments has been prevalent, but these options often lack robust bioactivity and are quickly broken down in the skin.

To address these challenges, Freda introduced two proprietary delivery methods for high-molecular-weight RHC-III. The first approach entailed a cell-penetrating peptide–fused recombinant collagen (CPP-RHC-III). This innovative system empowers collagen molecules with a unique